Long-term outcomes in patients younger than 60 years of age treated with brachytherapy for prostate cancer
ConclusionsLDR brachytherapy provides patients younger than 60 years of age with low and intermediate-risk prostate cancer excellent outcomes and has a low risk of significant long-term GU or gastrointestinal morbidity.
Source: Strahlentherapie und Onkologie - Category: Cancer & Oncology Source Type: research
More News: Brachytherapy | Cancer | Cancer & Oncology | Gastroenterology | Prostate Cancer | Study | Toxicology